IP Group plc
Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
- United Kingdom
- United States
- Australia
- New Zealand
Investment stages
- Seed
- Series A
- Growth
Industries
- Deep Tech
- Life Sciences
About
IP Group partners with top universities to create and scale research-led companies, primarily in deep-tech and biotechnology sectors. By focusing on university spinouts, IP Group aims to commercialize cutting-edge technologies that have the potential to transform industries and solve pressing global challenges. The firm provides both capital and extensive operational support, helping these ventures build strong foundations, attract talent, and navigate the journey from early research to successful commercialization.
IP Group partners with top universities to create and scale research-led companies, primarily in deep-tech and biotechnology sectors. By focusing on university spinouts, IP Group aims to commercialize cutting-edge technologies that have the potential to transform industries and solve pressing global challenges. The firm provides both capital and extensive operational support, helping these ventures build strong foundations, attract talent, and navigate the journey from early research to successful commercialization.
Investment Thesis
IP Group’s thesis is to create long-term value by turning scientific research into world-changing businesses. The firm invests in early-stage, research-led companies emerging from leading universities in sectors like deep tech, cleantech, and biotech, offering both financial capital and operational support to accelerate commercialization.
Manager's Experience
Led by experienced investment professionals with strong backgrounds in university spinouts, technology transfer, and life sciences investing.
Team
Greg Smith – CEO
David Baynes – CFO/COO
Dr. Mark Reilly – Managing Partner
Angela Leach – GC & Co Sec
Joyce Xie – MD
Global Capital.
Portfolio
Oxford Nanopore
First Light Fusion
Oxa
Hysata
Calm